{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:03:00Z","timestamp":1784275380119,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007834","name":"Ningbo Natural Science Foundation","doi-asserted-by":"crossref","award":["No.2024J422"],"award-info":[{"award-number":["No.2024J422"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ningbo Top Medical and Health Research Program","award":["No.2024020919"],"award-info":[{"award-number":["No.2024020919"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.32373099"],"award-info":[{"award-number":["No.32373099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Metabolic dysfunction-associated steatohepatitis (MASH), the progressive form of metabolic dysfunction-associated fatty liver disease (MAFLD), is tightly linked to gut microbiota dysbiosis and disrupted bile acid (BA) homeostasis. Floridoside (Flor), a marine glycoside from the edible seaweed\n                      <jats:italic>Pyropia haitanensis<\/jats:italic>\n                      (\n                      <jats:italic>P. haitanensis<\/jats:italic>\n                      ), exerts promising biological activities. However, protocols for its high-purity preparation and the mechanisms underlying its anti-MASH effects remain unclear.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      To develop a protocol for the preparation of high-purity Flor and its isomer isofloridoside (Isoflor) from\n                      <jats:italic>P. haitanensis<\/jats:italic>\n                      , and to elucidate how Flor alleviates MASH via regulating gut microbiota and BA metabolism.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>High-purity Flor and Isoflor were isolated via integrated chromatography, with their chemical structures confirmed by LC\u2013MS and NMR. Anti-MASH efficacy was evaluated in a high-fat diet (HFD)-induced murine MASH model. The underlying mechanisms were explored using multi-omics analyses, including transcriptomics, gut microbiota metagenomics and BA-targeted metabolomics, and further validated by molecular docking, molecular dynamics simulation and western blotting; the compounds\u2019 biosafety was evaluated using zebrafish.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      High-purity Flor and Isoflor were successfully isolated, each with a purity of\u2009\u2265\u200999.0%. Both compounds exhibited a favorable biosafety profile and comparable lipid-lowering activity in zebrafish. In HFD-induced murine MASH models, Flor robustly ameliorated HFD-driven obesity, hepatic steatosis, and chronic inflammation, and restored systemic BA homeostasis characterized by a markedly increased non-12-OH\/12-OH BA ratio. Meanwhile, Flor treatment dramatically enriched the relative abundance of intestinal\n                      <jats:italic>Parabacteroides goldsteinii<\/jats:italic>\n                      (\n                      <jats:italic>P. goldsteinii<\/jats:italic>\n                      ), which showed a significant positive correlation with MASH alleviation and beneficial BAs (e.g., ursodeoxycholic acid (UDCA)). Mechanistically, UDCA exerted its therapeutic effects by antagonizing FXR signaling, upregulating the hepatic protein and mRNA expression of CYP7B1 and CYP27A1, and ultimately promoting the activation of the alternative BA synthesis pathway.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      High-purity Flor and Isoflor were obtained via an integrated co-production process from\n                      <jats:italic>P. haitanensis<\/jats:italic>\n                      . We hypothesize that Flor may ameliorate MASH by enriching\n                      <jats:italic>P. goldsteinii<\/jats:italic>\n                      and modulating the UDCA-FXR axis to activate the alternative bile acid synthesis pathway, positioning Flor as a promising prebiotic candidate for MASH management.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01450-9","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:03:47Z","timestamp":1784271827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Co-production of high-purity floridoside and isofloridoside ameliorates MASH via Parabacteroides goldsteinii-UDCA-FXR enterohepatic axis"],"prefix":"10.1186","volume":"21","author":[{"given":"Shuang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JianJun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"1450_CR1","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jhep.2023.07.034","volume":"79","author":"L Adorini","year":"2023","unstructured":"Adorini L, Trauner M. FXR agonists in NASH treatment. J Hepatol. 2023;79:1317\u201331.","journal-title":"J Hepatol"},{"issue":"14","key":"1450_CR2","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1080\/00032719.2014.905950","volume":"47","author":"JJ Chen","year":"2014","unstructured":"Chen JJ, Song DD, Luo QJ, Mou T, Yang R, Chen HM, et al. Determination of floridoside and isofloridoside in red algae by high-performance liquid chromatography\u2013tandem mass spectrometry. Anal Lett. 2014;47(14):2307\u201316.","journal-title":"Anal Lett"},{"key":"1450_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111618","volume":"548","author":"JYL Chiang","year":"2022","unstructured":"Chiang JYL, Ferrell JM. Discovery of farnesoid X receptor and its role in bile acid metabolism. Mol Cell Endocrinol. 2022;548:111618.","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"1450_CR4","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.3390\/cells10102656","volume":"10","author":"I Evangelakos","year":"2021","unstructured":"Evangelakos I, Schwinge D, Worthmann A, John C, Roeder N, Pertzborn P, et al. Oxysterol 7-\u03b1 hydroxylase (CYP7B1) attenuates metabolic-associated fatty liver disease in mice at thermoneutrality. Cells. 2021;10(10):2656.","journal-title":"Cells"},{"issue":"2","key":"1450_CR5","first-page":"311","volume":"41","author":"YL Gao","year":"2017","unstructured":"Gao YL, Li JL, Yan XJ, Yang R, Zhang CD, Chen HM. Extraction of floridoside and the effect of floridoside on Ctenopharyngodon idella surimi during frozen storage. J Fish China. 2017;41(2):311\u20138.","journal-title":"J Fish China"},{"key":"1450_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/plb.12350","volume":"17","author":"M Hagemann","year":"2015","unstructured":"Hagemann M, Pade N. Heterosides-compatible solutes occurring in prokaryotic and eukaryotic phototrophs. Plant Biol. 2015;17:927\u201334.","journal-title":"Plant Biol"},{"key":"1450_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157172","volume":"147","author":"M Hu","year":"2025","unstructured":"Hu M, Yang J, Chen Y, Zhang Y, Liu CH, Feng Y, et al. Celastrol ameliorates metabolic dysfunction associated steatohepatitis by regulating the CYP7B1-mediated alternative bile acid synthetic pathway. Phytomedicine. 2025;147:157172.","journal-title":"Phytomedicine"},{"key":"1450_CR8","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1038\/s41467-019-12896-x","volume":"10","author":"F Huang","year":"2019","unstructured":"Huang F, Zheng X, Ma X, Jiang R, Zhou W, Zhou S, et al. Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism. Nat Commun. 2019;10:4971.","journal-title":"Nat Commun"},{"key":"1450_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3136\/fstr.27.95","volume":"27","author":"KJ Ishihara","year":"2021","unstructured":"Ishihara KJ, Seko T, Oyamada C, Kunitake H, Muraoka T. Synergistic effect of dietary glycerol galactoside and porphyran from nori on cecal immunoglobulin A levels in mice. Food Sci Technol Res. 2021;27:95\u2013101.","journal-title":"Food Sci Technol Res"},{"key":"1450_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13238-020-00804-9","volume":"12","author":"W Jia","year":"2021","unstructured":"Jia W, Wei M, Rajani C, Zheng X. Targeting the alternative bile acid synthetic pathway for metabolic diseases. Protein Cell. 2021;12:411\u201325.","journal-title":"Protein Cell"},{"key":"1450_CR11","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.cmet.2023.07.011","volume":"35","author":"J Kuang","year":"2023","unstructured":"Kuang J, Wang J, Li Y, Li M, Zhao M, Ge K, et al. Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis. Cell Metab. 2023;35:1752-1766.e8.","journal-title":"Cell Metab"},{"key":"1450_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.chom.2023.12.015","volume":"32","author":"T Li","year":"2024","unstructured":"Li T, Ding N, Guo H, Hua R, Lin Z, Tian H, et al. A gut microbiota-bile acid axis promotes intestinal homeostasis upon aspirin-mediated damage. Cell Host Microbe. 2024;32:1\u201318.","journal-title":"Cell Host Microbe"},{"key":"1450_CR13","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","volume":"385","author":"BA Neuschwander-Tetri","year":"2015","unstructured":"Neuschwander-Tetri BA, Loomba R, Sanyal AJ, Lavine JE, Van Natta ML, Abdelmalek MF, et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet. 2015;385:956\u201365.","journal-title":"Lancet"},{"key":"1450_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/md18020105","volume":"18","author":"TT Niu","year":"2020","unstructured":"Niu TT, Fu GQ, Zhou JW, Han H, Chen JJ, Wu W, et al. Floridoside exhibits antioxidant properties by activating HO-1 expression via p38\/ERK MAPK pathway. Mar Drugs. 2020;18:105.","journal-title":"Mar Drugs"},{"key":"1450_CR15","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jhep.2010.08.030","volume":"54","author":"V Ratziu","year":"2011","unstructured":"Ratziu V, de Ledinghen V, Oberti F, Mathurin P, Wartelle-Bladou C, Renou C, et al. A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. J Hepatol. 2011;54:1011\u20139.","journal-title":"J Hepatol"},{"key":"1450_CR16","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41586-021-03832-5","volume":"599","author":"Y Sato","year":"2021","unstructured":"Sato Y, Atarashi K, Plichta DR, Arai Y, Sasajima S, Kearney SM, et al. Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians. Nature. 2021;599:458\u201364.","journal-title":"Nature"},{"key":"1450_CR17","unstructured":"Shi LQ, Wang CG, Su GZ, Xue HY. A method for producing red algal glycosides and its specialized engineering bacteria. China Patent. 2024; Patent No. 201811353165."},{"key":"1450_CR18","volume-title":"The changes of floridoside content and the expression of stress resistance related genes in Pyropia haitanensis (Rhodophyta) under heat stress","author":"DD Song","year":"2014","unstructured":"Song DD. The changes of floridoside content and the expression of stress resistance related genes in Pyropia haitanensis (Rhodophyta) under heat stress. Ningbo: Ningbo University; 2014."},{"key":"1450_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12870-019-1928-2","volume":"19","author":"MX Sun","year":"2019","unstructured":"Sun MX, Zhu ZJ, Chen JJ, Yang R, Luo QJ, Wu W, et al. Putative trehalose biosynthesis proteins function as differential floridoside-6-phosphate synthases to participate in the abiotic stress response in the red alga Pyropia haitanensis. BMC Plant Biol. 2019;19:325.","journal-title":"BMC Plant Biol"},{"key":"1450_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.algal.2024.103780","volume":"84","author":"LC Tang","year":"2024","unstructured":"Tang LC, Ding HC, Qiu YF, Yan XH. The determining regions, specific genes and markers of sex in Pyropia haitanensis (Bangiales, Rhodophyta). Algal Res. 2024;84:103780.","journal-title":"Algal Res"},{"key":"1450_CR21","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.cmet.2024.03.011","volume":"36","author":"MA Tincopa","year":"2024","unstructured":"Tincopa MA, Anstee QM, Loomba R. New and emerging treatments for metabolic dysfunction-associated steatohepatitis. Cell Metab. 2024;36:912\u201326.","journal-title":"Cell Metab"},{"key":"1450_CR22","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/med.21991","volume":"44","author":"K Wang","year":"2024","unstructured":"Wang K, Zhang Y, Wang G, Hao H, Wang H. FXR agonists for MASH therapy: lessons and perspectives from obeticholic acid. Med Res Rev. 2024;44:568\u201386.","journal-title":"Med Res Rev"},{"key":"1450_CR23","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000763RRR","volume":"35","author":"X Wang","year":"2021","unstructured":"Wang X, Liu D, Wang Z, Li J, Zhang X, Chen H, et al. Porphyran-derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice. FASEB J. 2021;35:e21458.","journal-title":"FASEB J"},{"key":"1450_CR24","volume":"05","author":"Y Watanabe","year":"2023","unstructured":"Watanabe Y, Kinoshita K, Dumrongkulchart N, Sasaki T, Shimizu M, Yamauchi Y, et al. Downregulation of CYP7B1 caused by lipotoxicity associates with the progression of non-alcoholic steatohepatitis. bioRxiv. 2023;05:539979.","journal-title":"bioRxiv"},{"key":"1450_CR25","first-page":"116","volume":"40","author":"ST Yang","year":"2020","unstructured":"Yang ST, Chen JL, Liu Y, Xiao ZB, Hong PZ, Zhou CX. Effects of D-isofloridoside on invasion and metastasis of HT1080 tumor cells. J Guangdong Ocean Univ. 2020;40:116\u201322.","journal-title":"J Guangdong Ocean Univ"},{"key":"1450_CR26","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","volume":"394","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Ratziu V, Loomba R, Sanyal AJ, Neuschwander-Tetri BA, Lavine JE, et al. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 2019;394:2184\u201396.","journal-title":"Lancet"},{"key":"1450_CR27","unstructured":"Yue J, Liu LX, Chen YY, Bi YX, Chen B, Xi CH, Jiang LG. A method for industrial preparation of red algae glycosides. China Patent. 2021; Patent No. 201610086609."},{"key":"1450_CR28","doi-asserted-by":"publisher","first-page":"1173225","DOI":"10.3389\/fnut.2023.1173225","volume":"10","author":"LQ Zang","year":"2023","unstructured":"Zang LQ, Baharlooeian M, Terasawa M, Zhang Z, Hamid MR, Liu H. Beneficial effects of seaweed-derived components on metabolic syndrome via gut microbiota modulation. Front Nutr. 2023;10:1173225.","journal-title":"Front Nutr"},{"key":"1450_CR29","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1039\/D0FO00065E","volume":"11","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Fan XY, Guo WL, Li X, Liu Y, Wang Y, et al. The protective mechanisms of macroalgae Laminaria japonica consumption against lipid metabolism disorders in high-fat diet-induced hyperlipidemic rats. Food Funct. 2020;11:3256\u201370.","journal-title":"Food Funct"},{"issue":"1","key":"1450_CR30","first-page":"103","volume":"33","author":"JL Zhao","year":"2019","unstructured":"Zhao JL, Yang Y, Zhao Q, Zhong Q, Chen JJ, Yang R, et al. Different variations of floridoside and isofloridoside in Pyropia haitanensis under heat resistance. Journal of Nuclear Agricultural Sciences. 2019;33(1):103\u201311.","journal-title":"Journal of Nuclear Agricultural Sciences"},{"key":"1450_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12951-026-04288-3","volume":"24","author":"W Zhu","year":"2026","unstructured":"Zhu W, Han L, He L, Wei S, Li J, Xin L, et al. Parabacteroides goldsteinii-derived outer membrane vesicles alleviate acute lung injury via modulation of bile acid metabolism. J Nanobiotechnol. 2026;24:58.","journal-title":"J Nanobiotechnol"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01450-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01450-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01450-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:03:56Z","timestamp":1784271836000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01450-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1450"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01450-9","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments in this study were performed in strict accordance with relevant international guidelines and institutional regulations for animal research.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"197"}}